Related Experiment Video

Updated: Sep 7, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination

D J West1, G B Calandra, T M Hesley

  • 1Merck Research Laboratories, Department of Infectious Diseases, West Point, PA 19486.

Vaccine
|January 1, 1993
PubMed

Insights

Universal infant immunization against hepatitis B is crucial for controlling the virus in high-endemicity regions. Combining the hepatitis B vaccine with routine pediatric immunizations improves compliance and reduces liver disease.

Area of Science:

  • Public Health
  • Vaccinology
  • Hepatology

Background:

  • Hepatitis B virus (HBV) infection poses a significant global health burden, leading to acute and chronic liver disease.
  • In high endemicity areas, infants and children are primary targets for HBV infection, necessitating early intervention.
  • In lower endemicity regions, HBV infection predominantly affects adolescents and adults, requiring tailored prevention strategies.

Purpose of the Study:

  • To evaluate the efficacy of universal infant immunization for hepatitis B control in diverse epidemiological settings.
  • To assess the feasibility and benefits of integrating hepatitis B vaccination into routine pediatric immunization schedules.
  • To explore strategies for enhancing vaccine uptake and compliance, particularly in vulnerable populations.

Main Methods:

  • Review of clinical studies assessing antibody response to hepatitis B vaccine in infants and adults across various schedules.
  • Analysis of public health strategies for integrating hepatitis B vaccination with existing pediatric immunization programs.
  • Consideration of combination vaccine development to improve vaccination compliance and resource efficiency.

Main Results:

  • Clinical trials confirm that hepatitis B vaccination elicits protective antibody levels in a high proportion of healthy infants and adults.
  • Flexible scheduling and integration with routine immunizations are shown to enhance compliance.
  • Combination vaccines (e.g., DTaP-Hib-HepB) offer a promising approach to increase vaccination rates by reducing the number of required injections.

Conclusions:

  • Universal infant immunization is a cornerstone strategy for controlling hepatitis B, especially in highly endemic areas.
  • Integrating hepatitis B vaccine into routine pediatric schedules, potentially via combination vaccines, is effective and resource-efficient.
  • Successful hepatitis B control hinges on high vaccine coverage achieved through accessible and convenient immunization programs.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...